UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	March 10, 2022

Accession Number:	0001193125-22-031198
Submission Type:	POS AM
CIK: 0001654151 Company Name: Deciphera Pharmaceuticals, Inc. File Number: 333-236389